Top Healthcare Stocks
Healthcare stocks are mixed in late afternoon trade with the
NYSE Healthcare Sector Index rising less than 0.1% while shares of
healthcare companies in the S&P 500 are down about 0.1% as a
In company news, Cyclacel Pharmaceuticals Inc. (
) is up nearly 30% at $4.93 a share after the drug-maker released
updated data indicating its sapacitabine drug candidate has shown
anti-tumor activity against a majority of ovarian cancer samples
taken from patients, including resistant tumors.
"This observation may be directly related to the drug's
mechanism which is enhanced in cancer cells with reduced capacity
for DNA repair through the homologous recombination repair or HR
pathway," said Dr. Judy Chiao, head of clinical development and
regulatory affairs at CYCC.
The data were presented this week during the American
Association of Cancer Research annual conference in Miami.
In other sector news,
(+) TECH, RW Baird upgrade to Outperform from Neutral with
$90.00 price target.
(-) RNA, Said its prospective treatment for Duchenne muscular
dystrophy did not meet its primary endpoint during Phase III
testing of improving muscle function in boys and young men with the
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.